Construction and Stable Expression of A Truncated Human Receptor Tyrosine Kinase Ror1 (Ror1-Ecd)

Expression of receptor tyrosine kinase ror1 in a wide variety of cancers has emerged as a new era focusing on targeting this receptor in cancer therapy. our preliminary results indicate the presence of a truncated transcript of ror1 in tumor cells. the truncated ror1 encompasses extracellular and transmembrane domains, lacking catalytic kinase domain (ror1-ecd). as enzyme activity is highly dependent on the catalytic domain, we were wondering how this transcript and its encoded protein could play a possible role in tumorigenesis. to understand the function of this truncated transcript and whether or not the encoded protein translocates to the cell surface, we constructed a mammalian expression vector containing exon 1 to exon 8 of human ror1 gene as a model system. the encoded protein by this construct covers the entire extracellular and transmembrane domains of ror1. the chinese hamster ovary cell line (cho) was used for transfection. our results showed that this construct could express ror1- ecd at protein level and also the protein could effectively translocate to the surface of transfected cells. such model may suggest that a proportion of ror1 molecules expressed by tumor cells are not full-length ror1. this notion may be considered when applying flow cytometry using antibodies against ror1 for screening of tumor cells in order to avoid any miscalculation in the number of ror1 molecules expressed by tumor cells. furthermore, such expression may bring about assumptions on functional roles of ror1-ecd in tumorigenesis, which requires extensive functional studies.